Arbutus Biopharma (ABUS) Return on Capital Employed Growth (3y) (2017 - 2026)
Arbutus Biopharma (ABUS) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Arbutus Biopharma |
819.64 Mn |
819.64 Mn |
- |
12,929.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
12,929.00 |
| Dec 31, 2025 |
-307.00 |
| Sep 30, 2025 |
-1,417.00 |
| Jun 30, 2025 |
-2,397.00 |
| Mar 31, 2025 |
-4,222.00 |
| Dec 31, 2024 |
-2,106.00 |
| Sep 30, 2024 |
-1,413.00 |
| Jun 30, 2024 |
-1,291.00 |
| Mar 31, 2024 |
-1,831.00 |
| Dec 31, 2023 |
-1,412.00 |
| Sep 30, 2023 |
-382.00 |
| Jun 30, 2023 |
9,127.00 |
| Mar 31, 2023 |
9,509.00 |
| Dec 31, 2022 |
9,973.00 |
| Sep 30, 2022 |
6,620.00 |
| Jun 30, 2022 |
1,371.00 |
| Mar 31, 2022 |
663.00 |
| Dec 31, 2021 |
-247.00 |
| Sep 30, 2021 |
439.00 |
| Jun 30, 2021 |
-653.00 |
